Literature DB >> 26645868

Treatment of patients with uric acid stones.

Ita Pfeferman Heilberg1.   

Abstract

Uric acid nephrolithiasis and unduly acidic urinary pH are both considered a renal manifestation of insulin resistance but the underlying mechanisms for the development of low urinary pH and the propensity for uric acid stone formation are not completely elucidated. Nevertheless, excessive dietary acid intake, increased endogenous acid production and/or defective NH4+ excretion play an important role, among other factors. The main principles of therapy for uric acid nephrolithiasis are aimed at urinary alkalinization through diet modification or pharmacologic agents, increase of urinary volume, and less importantly at the reduction of uric acid excretion.

Entities:  

Keywords:  Acidic pH; Nephrolithiasis; Stones; Urate; Uric acid

Mesh：

Substances：

Year:  2015        PMID： 26645868     DOI： 10.1007/s00240-015-0843-8

Source DB:  PubMed          Journal:  Urolithiasis        ISSN： 2194-7228            Impact factor:   3.436


  62 in total

Review 1.  Does hyperuricosuria play a role in calcium oxalate lithiasis?

Authors:  B Ettinger
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

2.  Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.

Authors:  I Alexandru Bobulescu; Naim M Maalouf; Giovanna Capolongo; Beverley Adams-Huet; Tara R Rosenthal; Orson W Moe; Khashayar Sakhaee
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

3.  The effect of fruits and vegetables on urinary stone risk factors.

Authors:  Tiziana Meschi; Umberto Maggiore; Enrico Fiaccadori; Tania Schianchi; Simone Bosi; Giuditta Adorni; Erminia Ridolo; Angela Guerra; Franca Allegri; Almerico Novarini; Loris Borghi
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

4.  Uric acid and calcium oxalate nephrolithiasis.

Authors:  F L Coe
Journal:  Kidney Int       Date:  1983-09       Impact factor: 10.612

Review 5.  Metabolic syndrome and the genesis of uric acid stones.

Authors:  Naim M Maalouf
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

6.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

7.  The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.

Authors:  Vivian Barbosa Pinheiro; Alessandra Calábria Baxmann; Hans-Göran Tiselius; Ita Pfeferman Heilberg
Journal:  Urology       Date:  2013-04-18       Impact factor: 2.649

8.  Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

Authors:  F L Levy; B Adams-Huet; C Y Pak
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

9.  The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.

Authors:  MaryAnn Cameron; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Khashayar Sakhaee; Orson W Moe
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

Review 10.  Uric acid nephrolithiasis.

Authors:  Scott E Liebman; Jeremy G Taylor; David A Bushinsky
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686
View more
  8 in total

1.  In Reply.

Authors:  Bettina Engel
Journal:  Dtsch Arztebl Int       Date:  2017-07-24       Impact factor: 5.594

2.  The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Authors:  Yoshimi Tanaka; Shingo Hatakeyama; Toshikazu Tanaka; Hayato Yamamoto; Takuma Narita; Itsuto Hamano; Teppei Matsumoto; Osamu Soma; Teppei Okamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Ippei Takahashi; Shigeyuki Nakaji; Yuriko Terayama; Tomihisa Funyu; Chikara Ohyama
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 3.  Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review.

Authors:  A Abou-Elela
Journal:  J Adv Res       Date:  2017-04-28       Impact factor: 10.479

4.  Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.

Authors:  Yumaira Hernandez; Antonia Costa-Bauza; Paula Calvó; Joan Benejam; Pilar Sanchis; Felix Grases
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

5.  Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers.

Authors:  Seow Huey Choy; Selina Ann Nyanatay; Selvalingam Sothilingam; Rohan Malek; Sathiyananthan J R; Charng Chee Toh; Murali Sundram; Noor Ashani Md Yusoff; Poongkodi Nagappan; Shakirin Kamaruzaman; Wei Sien Yeoh; Teng Aik Ong; Jasmine Lim
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.752

6.  Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

7.  Effect of Consumption of Cocoa-Derived Products on Uric Acid Crystallization in Urine of Healthy Volunteers.

Authors:  Antonia Costa-Bauza; Felix Grases; Paula Calvó; Adrian Rodriguez; Rafael M Prieto
Journal:  Nutrients       Date:  2018-10-16       Impact factor: 5.717

8.  Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?

Authors:  Abdolreza Mohammadi; Mohammad Mehdi Rakebi; Maryam Gholamnezhad; Mahin Ahmadi Pishkuhi; Seyed Mohammad Kazem Aghamir
Journal:  Int Urol Nephrol       Date:  2021-05-29       Impact factor: 2.370
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.